NASDAQ : OPTH
Optimi Health Corp. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · Canada
Last price 2.41 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 14.77M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 14.77M |
| Enterprise Value | 9.09M |
Dates
| Measure | Value |
|---|
| Earnings Date | Dec 8, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 5.73M |
| Shares Outstanding | 5.73M |
| Shares Change (YoY) | +10.18% |
| Shares Change (QoQ) | +33.44% |
| Owned by Insiders (%) | 17.03% |
| Owned by Institutions (%) | 7.29% |
| Float | 4.65M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 119.43 |
| Forward PS | 17.81 |
| PB Ratio | 1.19 |
| P/TBV Ratio | 1.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 73.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.73 |
| Quick Ratio | 1.62 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -41.83 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -54.36% |
| Return on Assets (ROA) | -16.06% |
| Return on Invested Capital (ROIC) | -19.24% |
| Return on Capital Employed (ROCE) | -28.92% |
| Weighted Average Cost of Capital (WACC) | 10.74% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.01 |
| Inventory Turnover | 1.02 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.58 |
| 52-Week Price Change | -64.31% |
| 50-Day Moving Average | 4.25 |
| 200-Day Moving Average | 5.61 |
| Relative Strength Index (RSI) | 18.33 |
| Average Volume (20 Days) | 29,213 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 25,535 |
| Short Previous Month | 29,452 |
| Short % of Shares Out | 0.45% |
| Short % of Float | 0.55% |
| Short Ratio (days to cover) | 0.61 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 123,703 |
| Gross Profit | -216,989 |
| Operating Income | -3.62M |
| Pretax Income | -4.86M |
| Net Income | -4.86M |
| EBITDA | -2.96M |
| EBIT | -3.62M |
| Loss Per Share | -$1.41 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 9.21M |
| Total Debt | 3.62M |
| Net Cash | 5.58M |
| Net Cash Per Share | $0.98 |
| Equity (Book Value) | 12.42M |
| Book Value Per Share | 2.17 |
| Working Capital | 4.14M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -3.72M |
| Capital Expenditures | -78,430 |
| Depreciation & Amortization | 666,465 |
| Net Borrowing | 1.71M |
| Free Cash Flow | -3.80M |
| FCF Per Share | -$0.66 |
Margins
| Measure | Value |
|---|
| Gross Margin | -175.41% |
| Operating Margin | -2,925.72% |
| Pretax Margin | -3,928.63% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -10.18% |
| Shareholder Yield | n/a |
| Earnings Yield | -58.70% |
| FCF Yield | -25.70% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 72.97% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | May 20, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.09 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |